SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________________________
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
____________________________________
Date of report (Date of earliest event reported): December
12, 1997
CRYOMEDICAL SCIENCES, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware 0-18170
94-3076866
(State or Other Juris- (Commission File
No.) (IRS Employer
diction of Incorporation)
Identification No.)
1300 Piccard Drive, Suit 102, Rockville, MD
20850
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
(301) 417-7070
N/A
(Former Name or Former Address, if Changed Since
Last Report.)<PAGE>
Item 7 of the Current Report on Form 8-K of
Cryomedical Sciences, Inc. dated December 19, 1997 is
hereby amended and restated as follows:
ITEM 7. Financial Statements, Pro Forma
Financial Information and Exhibits
(c) Exhibits
(1) Letter from Deloitte & Touche
LLP dated December 22, 1997.
<PAGE>
Signatures:
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned
hereunto duly authorized.
CRYOMEDICAL SCIENCES, INC.
By:/s/ Richard Reinhart
Richard Reinhart
President and Chief Executive Officer
Date: December 29, 1997
<PAGE>
[Deloitte & Touche LLP Letterhead]
December 22, 1997
Securities and Exchange Commission
Mail Stop 9-5
450 5th Street, NW
Washington, DC 20549
Dear Sirs/Madams:
We have read and agree with the comments in Item 4 of
Form 8-K of Cryomedical Sciences, Inc. dated
December 19, 1997.
Yours truly,
/s/ Deloitte & Touche LLP
